With the analysis among 2,972 patents, we discovered top 329 key players by total patent application. Genentech, Inc., F. Hoffmann-La Roche Ltd., Roche Glycart AG are dominant in this area. They take 38.86% of the total patent filing.
California, United States
Patent: 577
F. Hoffmann-La Roche Ltd.
ZURICH, Switzerland
Patent: 220
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 157
Hovedstaden, Denmark
Patent: 138
Massachusetts, United States
Patent: 93
New Jersey, United States
Patent: 84
Basel-Stadt, Switzerland
Patent: 77
Emergent Product Development Seattle
Washington, United States
Patent: 39
Laboratoire Francais du Fractionnement et des Biotechnologies S.A.
With the analysis among 51 patents, we discovered top 12 start-ups by total patent application. Forty Seven, Inc., DRAGONFLY Therapeutics, Inc., ImmuneOnco Biopharmaceuticals (Shanghai) Co Ltd are active in this area.
California, United States
Patent: 18
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 9
ImmuneOnco Biopharmaceuticals (Shanghai) Co Ltd
Shanghai Shi, China
Patent: 6
Palleon Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 4
Institut National de la Santé et de la Recherche Médicale
Adicet Therapeutics, Inc.
California, United States
Patent: 2
Artiva Biotherapeutics, Inc.
California, United States
Patent: 2
KANAPH Therapeutics, Inc.
California, United States
Patent: 2
Hrain Biotechnology Co. Ltd.
Shanghai Shi, China
Patent: 1
With the analysis among related 802 patents applied in the last 5 years. We discover 202 most active companies in this area. The fast-growing Genmab A/S, F. Hoffmann-La Roche Ltd., Genentech, Inc. take 23.44% of patent filing during this period.
Hovedstaden, Denmark
Patent: 71
F. Hoffmann-La Roche Ltd.
California, United States
Patent: 46
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 34
New Jersey, United States
Patent: 26
Cellular Biomedicine Group, Inc.
California, United States
Patent: 24
Zakrytoe Aktsionernoe Obshchestvo Biokad
California, United States
Patent: 18
Basel-Stadt, Switzerland
Patent: 15
Sorrento Therapeutics, Inc.
California, United States
Patent: 14
With the analysis among related 802 patents in last 5 years, we discover 132 new entrants. Cellular Biomedicine Group, Inc., Zakrytoe Aktsionernoe Obshchestvo Biokad, Forty Seven, Inc. are the most active new entrants in this area.
Cellular Biomedicine Group, Inc.
California, United States
Patent: 24
Zakrytoe Aktsionernoe Obshchestvo Biokad
California, United States
Patent: 18
Sorrento Therapeutics, Inc.
California, United States
Patent: 14
Otsuka Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 13
California, United States
Patent: 12
Heidelberg Pharma Research GmbH
New Jersey, United States
Patent: 10
California, United States
Patent: 10
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 9
With the analysis among 353 patents, we discovered top 46 universities and scientific research institutions by total patent application. Duke University, The University of Southampton, Osaka University are dominant in this area. They take 28.05% of the total patent filing.
North Carolina, United States
Patent: 20
The University of Southampton
SOUTHAMPTON, United Kingdom
Patent: 20
Osaka-fu, Japan
Patent: 16
Oost-Vlaanderen, Belgium
Patent: 11
Vlaams Instituut voor Biotechnologie - Flanders Institute
Swiss Federal Institute of Technology Zurich
ZURICH, Switzerland
Patent: 7
ZURICH, Switzerland
Patent: 7
Zhejiang Sheng, China
Patent: 6
New York, United States
Patent: 5
Beijing Shi, China
Patent: 5